Medivir: Birinapant is given attention at ASCO

Research Note

2019-05-16

11:10

Results from the completed Phase I combination study with birinapant and Keytruda will be presented during the ASCO conference in Chicago. The abstract released last night confirms what has previously been announced from Medivir.

KP

Klas Palin

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.